Who are 0 2 AstronauTx's investors?

0 2 AstronauTx's investors include MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.

0 2 AstronauTx

Founded 2019 · 26 employees on LinkedIn · 5 known investors

Find your way into 0 2 AstronauTx

511 people in our graph share verified history with the 0 2 AstronauTx team — schools, employers, funds. One of them is your warm intro.

Hani Goodarziunlockedknows Jane Rhodes · together at Verge Genomics (overlapped)

×5knows the team · via Verge Genomics

×4knows the team · via Amgen

×2knows the team · via PepGen

AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.

Biotech Deep Tech Healthtech Longevity Medical Devices

Founders & leadership

Jane Rhodes Chief Executive OfficerJane Rhodes is a neuroscientist and CEO of AstronauTx, a biotechnology company developing drug candidates for neurodegenerative and neuroinflammatory diseases.

Magnus IvarssonChief Scientific Officer

Hannah PearceChief Operating Officer

Michelle L. Mellion Chief Medical OfficerMichelle L. Mellion is a board-certified neurologist and clinical neurophysiologist with over 20 years of experience in clinical care, research, and drug development across biotech. She trained at Wake Forest University School of Medicine and Brown University, served as Neurology Residency Program Director and Clinical Neurophysiology Fellowship Director at Brown, and has led early- and late-phase clinical trial programs in CNS disorders including neurodegeneration and neuromuscular disease.

Investors · 5

MPM BioImpactBoston · $1M – $15M

Novartis Venture FundBasel · $5M – $25M

SV Health InvestorsBoston · $1M – $20M

UCL Technology FundLondon · $320K – $9M

AlbionVCreportedLondon

Frequently asked questions

What does 0 2 AstronauTx do?: AstronauTx is a biotechnology company focused on drug discovery and development for neurodegenerative and neuroinflammatory diseases, working across small molecules and biologics. Its programs target areas such as Alzheimer's disease, sleep, and other CNS disorders.
Who are 0 2 AstronauTx's investors?: 0 2 AstronauTx's investors include MPM BioImpact, Novartis Venture Fund, SV Health Investors, UCL Technology Fund, AlbionVC.